Contract 256336 amendment 4 for a funds increase

This is a sole source, non-competitive contract amendment (Contract 256336 Amendment 4) issued by the State of Utah Department of Health and Human Services, Division of Integrated Healthcare, through the Department of Government Operations Division of Purchasing. The procurement involves awarding a funds increase to Public Consulting Group, LLC, to conduct independent, CMS-required evaluations of Utah's 1115 Demonstration Waiver through December 31, 2029. The scope of work encompasses quantitative data collection and analysis, project management, evaluation design document revisions, and preparation of a summative evaluation report due in December 2028. The evaluation will assess three new 1115 Demonstration populations added to the waiver: Family Planning services, inclusion of pregnant women and children in fee-for-service dental coverage, and 12-month continuous postpartum coverage. Key deliverables include comprehensive evaluation activities addressing amendments to the waiver, including the transition of dental services into the demonstration in partnership with the University of Utah School of Dentistry, the conclusion of the ISS program, and the removal of the HRSS program. The evaluation period spans July 1, 2022, through June 30, 2027, with contract work extending through December 31, 2029, and the notice of intent to award was posted on March 6, 2026, with a due date of March 13, 2026.

This procurement is being awarded on a sole source, non-competitive basis without engaging in a standard procurement process, meaning no open competitive bidding will occur and only Public Consulting Group, LLC, is eligible to be awarded this contract amendment. No specific set-asides for disadvantaged enterprises or other organizational restrictions are indicated in the available documentation. Public Consulting Group, LLC, is the incumbent contractor on the existing Contract 256336, which commenced January 1, 2021, and the organization possesses the specialized expertise and institutional knowledge required to continue seamless evaluation activities across the multi-year demonstration waiver period. The amendment represents a significant funds increase to the existing sole source contract, with the current total increasing from $5,770,676 to $6,090,376—representing a $319,700 increase attributed to adding evaluation funds for the three new 1115 Demonstration populations. Cost allocation by demonstration year ranges from $13,982 in FY27 to $250,340 in FY26, with annual project management costs of $8,340 and quantitative data analysis costs of $4,375 per fiscal year.